3 assets in Post-COVID-19 Disorder

Therapeutic assets addressing Post-COVID-19 Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Oxygen Post-COVID-19 Disorder	Jay C. Buckey Jr.	P4	BB (64)
Vortioxetine Post-COVID-19 Disorder	Brain and Cognition Discovery Foundation	P2	B (57)
Marcaine Post-COVID-19 Disorder	Jonathann Kuo, MD	P1	CC (47)